Full-Time

Therapy Area Head

Dermatology and Respiratory

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior, Expert

Reading, UK

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • UK registered MBBS, MPharm is preferred with current ABPI signatory status
  • Significant pharmaceutical industry experience covering leadership of a broad set of medical activities, including clinical trials, medical affairs and external engagement
  • Ability to lead, manage and develop teams
  • Preferred knowledge of specific products and related therapeutics areas, including Key Opinion Leaders
  • Knowledge of the structure and management of the NHS and its evolution
Responsibilities
  • Lead the high calibre Medical Affairs team to foster a culture of positive collaboration, influencing across networks and deliver to all stakeholders across the franchise
  • Drive implementation of innovation and digital capabilities as a core focus and RWE generation to assist prioritising data for HTA submission and post MA studies
  • Be the leader across UKIE and above country with a solution orientated approach
  • Lead development or proactive relationships across the UK healthcare environment and part of a co-ordinated stakeholder plan. Work collaboratively with patient advocacy to ensure patient centricity and with National bodies, guideline committees, patient and policy organisations
  • Internal interactions – Work with the commercial franchise heads on the franchise plan, ensuring appropriate resource allocation and be accountable for medically lead activities. Close working with Medical Information, PV, Regulatory Affair and regional/global affiliates for best practice and gain approval for medical TA project
  • People leadership – driving the Sanofi Play to Win behaviours, developing people through efficient coaching and driving motivated and fully engaged teams

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi differentiates itself from competitors by its strong commitment to scientific innovation and a diverse product portfolio that includes prescription medicines and vaccines. Its goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Therapy designation for tolebrutinib boosts Sanofi's neurology portfolio.
  • Dupixent's EU approval expands Sanofi's pediatric treatment offerings.
  • Sanofi's investment in Zucara Therapeutics strengthens its diabetes treatment pipeline.

What critics are saying

  • Liver enzyme elevations in tolebrutinib trials may lead to regulatory scrutiny.
  • Competition in multiple sclerosis market could impact tolebrutinib's market share.
  • AI tools like Muse may face challenges from stringent data privacy regulations.

What makes Sanofi unique

  • Sanofi's partnership with BrightInsight enhances digital health solutions for specialty therapies.
  • Tolebrutinib is the first brain-penetrant BTK inhibitor for multiple sclerosis.
  • Sanofi's Muse AI tool optimizes patient recruitment in clinical trials.

Help us improve and share your feedback! Did you find this helpful?